Re-sequencing of the candidate genomic region in 18 probands from European families with suspected or confirmed HLRCC confirmed the presence of FH mutations in nine of them as previously reported (Smit et al. 2011). This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.